Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Post by general360on Feb 04, 2021 2:13pm
268 Views
Post# 32472188

valuation?

valuation?
so deloitte and douchebag put together a valuation that we're not allowed to see?  how's that different than what our "analysts" do?  where's their valuation?  Is it different than D&D?  why?  oh wait, we dont have analysts and we sure as shyte cant see the D&D report...only the fine saudis can, and there's a delay of pushing that transfer button....button must be broke, like us.... so the rest of us get Zack's "analyst" report of valuations...insiders get the douchebag report...

hopefully we get the money by the end of the month...  that's what i like to invest in: HOPE....not facts, or alternative facts even, just HOPE....empty, strung along HOPE....

NO updates on PAH....

frick and frack, nothing to say?  chokin on yer kool-aid?  OH YEAH....

<< Previous
Bullboard Posts
Next >>